Skip to main content
  • ASM Journals
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Research and News from ASM Journals
    • mSphere of Influence: Commentaries from Early Career Microbiologists
    • Archive
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Getting Started
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mSphere
    • Editor in Chief
    • Board of Editors
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • ASM Journals
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
mSphere
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Research and News from ASM Journals
    • mSphere of Influence: Commentaries from Early Career Microbiologists
    • Archive
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Getting Started
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mSphere
    • Editor in Chief
    • Board of Editors
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
Observation | Applied and Environmental Science

Novel β-Lactamase blaARL in Staphylococcus arlettae

Sabrina N. Andreis, Vincent Perreten, Sybille Schwendener
Mariana Castanheira, Editor
Sabrina N. Andreis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent Perreten
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vincent Perreten
Sybille Schwendener
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mariana Castanheira
JMI Laboratories
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/mSphere.00117-17
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Whole-genome sequencing of penicillin-resistant Staphylococcus arlettae strain SAN1670 from bovine mastitis milk revealed a novel β-lactamase operon consisting of the β-lactamase-encoding gene blaARL, the antirepressor-encoding gene blaR1ARL, and the repressor-encoding gene blaIARL. The functionality of blaARL was demonstrated by gene expression in Staphylococcus aureus. The blaARL operon was chromosomally located in SAN1670 and present in 10 additional unrelated strains, suggesting intrinsic penicillin resistance in S. arlettae. Furthermore, a GenBank search revealed more unique potential β-lactamases in Staphylococcus species.

IMPORTANCE Penicillins are an important group of antibiotics used to treat various types of infections caused by Gram-positive bacteria. So far, the blaZ gene was the only known β-lactamase gene in staphylococci. However, other putative β-lactamases were identified, and one of them was shown to be a novel functional β-lactamase encoded by blaARL in Staphylococcus arlettae, further limiting treatment options.

OBSERVATION

Staphylococcus arlettae is a ubiquitous coagulase-negative staphylococcus first isolated from the skin and nares of poultry and goats, respectively (1). Later, it was also found in the environment of tobacco fermentation (Culture Collection, University of Göteborg [CCUG], Göteborg, Sweden), the skin of horses (2), and bovine teat skin (3). In some cases, it was associated with bovine mastitis (4). Today, the intramammary application of penicillin alone or in combination with other antibiotics is the mastitis treatment method most frequently used in dairy cows (5). However, penicillin can be hydrolyzed by β-lactamase-producing staphylococci that have acquired the blaZ gene, so far the only known β-lactamase gene in staphylococci (6). This gene is organized in an operon with the antirepressor-encoding gene blaR1 and the repressor-encoding gene blaI. BlaR1 and BlaI form a regulatory two-component system responsible for inducible blaZ expression in the presence of β-lactam antibiotics (7, 8). The blaZ gene is widespread in several Staphylococcus species, including Staphylococcus aureus (6, 9), and has been found on different mobile genetic elements like transposon Tn552 and conjugative plasmids (10–12).

In 2010, penicillinase-producing S. arlettae strain SAN1670 was isolated from a bovine mastitis milk sample at our institute in Switzerland. PCR failed to identify the blaZ gene, prompting us to determine the nature of this β-lactamase phenotype by whole-genome sequencing. This allowed us to identify a novel functional β-lactamase in S. arlettae. Searching for further bla homologs in the gene pool of Staphylococcus revealed several uncharacterized potential β-lactamase sequences.

Novel β-lactamase blaARL on the chromosome of S. arlettae SAN1670.The whole-genome sequence of S. arlettae SAN1670 was obtained by using Illumina MiSeq technology and reagent kit v 2 (Illumina, Inc., San Diego, CA) at the Labormedizinisches Zentrum Risch, Liebefeld-Bern, Switzerland. Reads were assembled into contigs with Geneious version R9.1.5 (13). TBLASTn analysis (http://www.ncbi.nlm.nih.gov/blast/ ) of the contigs generated revealed a distantly related blaZ homolog on a 145-kb contig (GenBank accession number KY363215 ). This blaZ homolog was named blaARL, where bla defines the gene and ARL is the enzyme, in accordance with the nomenclature used for other β-lactamases (14). The 849-bp blaARL gene encodes a 282-amino-acid protein containing the consensus pattern for the β-lactamase class A active site (PS00146) defined in the Prosite database (15). The active-site serine present in all class A, C, and D β-lactamases was identified at position 63 of the ARL enzyme. The blaARL gene was preceded by two regulatory genes, blaIARL and blaR1ARL, transcribed in the opposite direction, forming a β-lactamase operon similar to blaI-blaR1-blaZ. This operon had 55% overall nucleotide sequence identity with Tn552 (GenBank accession number X52734 ) (11) and is expected to be responsible for inducible blaARL expression in S. arlettae SAN1670. Analysis of a 50-kb region on each side of the blaARL gene identified genes belonging to the core genome of staphylococci such as xprI, pbuX, guaA, and guaB, which are involved in purine metabolism, as well as rpsR, rpsF, and ssb, which encode ribosomal proteins and a single-strand DNA-binding protein. The absence of transposases or recombinases within this region indicates that blaARL is stably integrated into the chromosome.

Identification of bla homologs in staphylococci.A search for ARL enzyme homology in all of the available staphylococcal sequences in the NCBI GenBank database showed that the blaARL gene was also present in shotgun genomes of S. arlettae strains CVD059 (GenBank accession number ALWK01000016 ) (16) and EGD-HP3 (GenBank accession number AVOQ01000023 ). These blaARL genes were 99.5% identical and had 94% nucleotide sequence identity and 97% amino acid sequence identity with blaARL of SAN1670. Alignment of blaARL with blaZ of S. aureus NCTC 9789 (GenBank accession number X52734 ) (11) resulted in only 59% nucleotide sequence identity between the genes and 48% amino acid sequence identity between the β-lactamases ARL and PC1 encoded by blaZ. The PC1 enzyme is widespread in staphylococci and was identified in 27 different species (Fig. 1). Additional putative β-lactamases containing the class A consensus pattern (PS00146) were also detected. Four of these β-lactamases were found in the class E mec gene complex and clustered into a group with 67 to 71% amino acid sequence identity with PC1 and 46 to 49% amino acid sequence identity with ARL (Fig. 1). The other eight uncharacterized β-lactamases were unrelated and had 47 to 67% amino acid sequence identity with PC1 and 47 to 56% amino acid sequence identity with ARL (Fig. 1). These putative β-lactamases were unique to the species they belonged to, and none of them were preceded by the regulatory genes blaI and blaR1, such as in blaZ and blaARL operon.

FIG 1
  • Open in new tab
  • Download powerpoint
FIG 1

Phylogenetic tree of β-lactamases encoded by staphylococci. Evolutionary analysis was performed for amino acid sequences by the unweighted pair group method using average linkages in MEGA7. Evolutionary distances were computed by the Poisson correction method and were measured as the number of amino acid substitutions per site. The percentages of amino acid and nucleotide sequence identity between blaARL and other β-lactamases were determined by sequence alignment with Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/ ). Roman numerals indicate β-lactamase groups as follows: I, blaZ; II, blaARL; III, β-lactamases of the class E mec gene complex; IV, group of diverse uncharacterized β-lactamases.

Expression of blaARL in S. aureus.To prove the functionality of the novel β-lactamase of S. arlettae, the blaARL gene was cloned with and without the regulator genes blaIARL and blaR1ARL from SAN1670 and expressed in S. aureus RN4220. The entire blaIARL-blaR1ARL-blaARL operon was amplified with primers blaR1_M1670-XhoI-F and bla_M1670-PstI-R (see Table S1 in the supplemental material for the primers and PCR conditions used). The resulting fragment was cloned into the XhoI and PstI restriction sites of the S. aureus-Escherichia coli shuttle vector pTSSCm (17) to generate plasmid pSAN01. The blaARL gene alone was amplified with primers bla_M1670-NdeI-F and bla_M1670-SpeI-R (see Table S1) and inserted downstream of the type 1 capsule gene 1A promoter (Pcap) of pBUS1-Pcap-HC (17) to generate plasmid pSAN02. Plasmids pSAN01 and pSAN02 were transformed into E. coli DH5α and selected for tetracycline resistance (10 µg/ml) encoded on the vectors. Sanger sequencing confirmed the correct blaARL operon sequence in pSAN01; therefore, the plasmid was electroporated into RN4220 (18). However, nonsense mutations were observed at the 5′ end of the blaARL gene in all of the pSAN02 plasmids sequenced, indicating that constitutive β-lactamase expression could be deleterious to E. coli. To reverse the mutation in blaARL from pSAN02, QuikChange site-directed mutagenesis was performed directly in S. aureus RN4220. A missing thymidine (T) in the T stretch at gene positions 10 to 15 in a faulty plasmid was introduced by PCR (Phusion Hot Start II High-Fidelity DNA Polymerase; Thermo Fisher Scientific, Waltham, MA) with overlapping primers mut_M1670-F (5′-GGTTTATCATATGAAAAAGTTTTTTACTATCTTTGTCTTACTCTG) and mut_M1670-R (5′-CTTTTTCATATGATAAACCTCCTATTTTCCTTTCTTGTTTTC) (the T stretch is italic, and the start codon of blaARL is bold) (19). The reaction product was treated with the DpnI restriction enzyme and directly electroporated into RN4220 cells to obtain plasmid pSAN02mut. Sequencing of the mutagenized plasmid in RN4220 clones confirmed the correct sequence of blaARL. Furthermore, pSAN02mut isolated from RN4220 could not be transformed into E. coli, confirming that the constitutive expression of blaARL from Pcap is not compatible with E. coli.

TABLE S1

Primers and PCR conditions used in this study. Download TABLE S1, PDF file, 0.3 MB.
Copyright © 2017 Andreis et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license .

The production of a functional β-lactamase by S. aureus RN4220 containing pSAN01 and pSAN02mut was demonstrated by a positive nitrocefin test on BBL DrySlide nitrocefin (Becton, Dickinson and Company, Franklin Lakes, NJ) and by increased resistance to penicillin (Table 1) but not to other β-lactams, including ceftriaxone, cefaclor, cefepime, cefixime, cefuroxime, ertapenem, cefepime, cefotaxime, imipenem, ceftazidime, and temocillin. MICs were determined by microdilution in cation-adjusted BBL Mueller-Hinton II Broth (Becton, Dickinson and Company) with EUST, HPB1, and EUVSEC2 Sensititre Plates (Thermo Fisher Scientific) in accordance with CLSI guidelines (20).

View this table:
  • View inline
  • View popup
TABLE 1

Staphylococcus strain characteristics and origins and MICs of β-lactam antibiotics

The MICs of both penicillin and ampicillin were higher for RN4220/pSAN02mut expressing blaARL constitutively than for RN4220/pSAN01 containing blaARL regulated by blaIARL and blaR1ARL (Table 1). Higher MICs of the cephalosporin cefoxitin and the carbapenem meropenem, with a 2-fold increase, were also observed with pSAN02mut. This is likely to be a side effect of overproduction of ARL, a protein that can bind β-lactams. It is unlikely that ARL can hydrolyze these β-lactam rings since class A β-lactamases like PC1 are primarily penicillinases and are not expected to have any cephalosporinase or carbapenemase activity (21). Absence of carbapenemase activity was confirmed with the Blue-Carba test (22).

Distribution of blaARL in S. arlettae.Ten additional S. arlettae strains from different origins were tested for β-lactam resistance (Table 1). All displayed decreased susceptibility to penicillin with a MIC above the CLSI resistance breakpoints (20). Production of β-lactamase by the nitrocefin slide method was also observed in all of the strains except SAN2420, which was negative in this test. All strains were positive for blaARL by PCR with primers blaARL-F (5′-CTATCTTTGTCTTACTCTGTGT) and blaARL-R (5′-GCMTGACGTGCTGCTTGTGC) (see Table S1). Analysis of the blaARL region by PCR and Sanger sequencing revealed an intact blaIARL-blaR1ARL-blaARL operon. The operon was located between open reading frames encoding a MaoC-like domain-containing protein and a peptide ABC transporter permease, the same as in the sequenced strains SAN1670, CVD059, and EGD-HP3 (see Table S1). The blaIARL-blaR1ARL-blaARL operon sequences of the 10 S. arlettae strains have 88 to 100% nucleotide sequence identity with that of SAN1670.

The universal presence of blaARL in all of the tested S. arlettae strains from different sources suggests intrinsic penicillin resistance in this species. The blaIARL-blaR1ARL-blaARL operon seems to be a stable part of the core genome and not to be associated with any recombinase. However, the location between guaA and rpsR, integration hot spots for genomic islands (23, 24), suggests a potential for blaARL mobilization. In addition, diverse proteins containing typical β-lactamase motifs appear to be present in many different Staphylococcus species. They lack the antirepressor blaR1 and repressor blaI genes, and their role in β-lactam resistance is unclear. Our data propose a broader genetic analysis of penicillin-resistant staphylococci that do not contain blaZ. They also show that the presence of a functional β-lactamase in S. arlettae is presumable and jeopardizing penicillin treatment. The identification of the pathogen, as well as antimicrobial susceptibility testing, is therefore necessary for correct and effective therapy.

Accession number(s).The sequence of the blaARL-containing contig of S. arlettae SAN1670 has been deposited in the GenBank database under accession number KY363215 . The sequence of the blaIARL-blaR1ARL-blaARL operon of S. arlettae strain ILRI338 has been deposited under accession number KY464892 , and those of strains CCUG 50677, BM242, CCUG 32416, CSKR33, SAN1988, SAN2420, SAN2677, SAN2690, and CCUG 33610 have been deposited under accession numbers KY363206 to KY363214 , respectively.

ACKNOWLEDGMENTS

This study was financed by research grant 35-539 from the Institute of Veterinary Bacteriology, University of Bern, Bern, Switzerland, and by grant 1.15.07 from the Federal Food Safety and Veterinary Office within the framework of the Animal Health and Welfare ERA-Net project.

We thank the Center for Zoonoses, Animal Bacterial Diseases and Antimicrobial Resistance (ZOBA), Institute of Veterinary Bacteriology, University of Bern, for providing mastitis isolates; Carlotta Sartori and Hans U. Graber, Agroscope, Liebefeld-Bern, for strain BM242; Anne Liljander, International Livestock Research Institute, Nairobi, Kenya, for strain ILRI338; Nadia Wohlwend, Labormedizinisches Zentrum Risch, Liebefeld-Bern, for sequencing strain SAN1670; and Alexandra Collaud, Institute of Veterinary Bacteriology, Bern, Switzerland, for technical assistance.

FOOTNOTES

    • Received March 9, 2017.
    • Accepted April 12, 2017.
  • Copyright © 2017 Andreis et al.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license .

REFERENCES

  1. 1.↵
    1. Schleifer KH,
    2. Kilpper-Bälz R,
    3. Devriese LA
    . 1984. Staphylococcus arlettae sp. nov., S. equorum sp. nov. and S. kloosii sp. nov.: three new coagulase-negative, novobiocin-resistant species from animals. Syst Appl Microbiol5:501–509. doi:10.1016/S0723-2020(84)80007-7.
    OpenUrlCrossRefWeb of Science
  2. 2.↵
    1. Schnellmann C,
    2. Gerber V,
    3. Rossano A,
    4. Jaquier V,
    5. Panchaud Y,
    6. Doherr MG,
    7. Thomann A,
    8. Straub R,
    9. Perreten V
    . 2006. Presence of new mecA and mph(C) variants conferring antibiotic resistance in Staphylococcus spp. isolated from the skin of horses before and after clinic admission. J Clin Microbiol44:4444–4454. doi:10.1128/JCM.00868-06.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Verdier-Metz I,
    2. Gagne G,
    3. Bornes S,
    4. Monsallier F,
    5. Veisseire P,
    6. Delbès-Paus C,
    7. Montel MC
    . 2012. Cow teat skin, a potential source of diverse microbial populations for cheese production. Appl Environ Microbiol78:326–333. doi:10.1128/AEM.06229-11.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. dos Santos Nascimento J,
    2. Fagundes PC,
    3. de Paiva Brito MA,
    4. dos Santos KR,
    5. do Carmo de Freire Bastos M
    . 2005. Production of bacteriocins by coagulase-negative staphylococci involved in bovine mastitis. Vet Microbiol106:61–71. doi:10.1016/j.vetmic.2004.10.014.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. De Briyne N,
    2. Atkinson J,
    3. Pokludová L,
    4. Borriello SP
    . 2014. Antibiotics used most commonly to treat animals in Europe. Vet Rec175:325. doi:10.1136/vr.102462.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Lowy FD
    . 2003. Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest111:1265–1273. doi:10.1172/JCI18535.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Hackbarth CJ,
    2. Chambers HF
    . 1993. blaI and blaR1 regulate β-lactamase and PBP 2a production in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother37:1144–1149. doi:10.1128/AAC.37.5.1144.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Zhang HZ,
    2. Hackbarth CJ,
    3. Chansky KM,
    4. Chambers HF
    . 2001. A proteolytic transmembrane signaling pathway and resistance to β-lactams in staphylococci. Science291:1962–1965. doi:10.1126/science.1055144.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Klimiene I,
    2. Virgailis M,
    3. Pavilonis A,
    4. Siugzdiniene R,
    5. Mockeliunas R,
    6. Ruzauskas M
    . 2016. Phenotypical and genotypical antimicrobial resistance of coagulase-negative staphylococci isolated from cow mastitis. Pol J Vet Sci19:639–646. doi:10.1515/pjvs-2016-0080.
    OpenUrlCrossRef
  10. 10.↵
    1. Olsen JE,
    2. Christensen H,
    3. Aarestrup FM
    . 2006. Diversity and evolution of blaZ from Staphylococcus aureus and coagulase-negative staphylococci. J Antimicrob Chemother57:450–460. doi:10.1093/jac/dki492.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Rowland SJ,
    2. Dyke KG
    . 1990. Tn552, a novel transposable element from Staphylococcus aureus. Mol Microbiol4:961–975. doi:10.1111/j.1365-2958.1990.tb00669.x.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Shearer JE,
    2. Wireman J,
    3. Hostetler J,
    4. Forberger H,
    5. Borman J,
    6. Gill J,
    7. Sanchez S,
    8. Mankin A,
    9. Lamarre J,
    10. Lindsay JA,
    11. Bayles K,
    12. Nicholson A,
    13. O’Brien F,
    14. Jensen SO,
    15. Firth N,
    16. Skurray RA,
    17. Summers AO
    . 2011. Major families of multiresistant plasmids from geographically and epidemiologically diverse staphylococci. G3 (Bethesda)1:581–591. doi:10.1534/g3.111.000760.
    OpenUrlCrossRef
  13. 13.↵
    1. Kearse M,
    2. Moir R,
    3. Wilson A,
    4. Stones-Havas S,
    5. Cheung M,
    6. Sturrock S,
    7. Buxton S,
    8. Cooper A,
    9. Markowitz S,
    10. Duran C,
    11. Thierer T,
    12. Ashton B,
    13. Meintjes P,
    14. Drummond A
    . 2012. Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics28:1647–1649. doi:10.1093/bioinformatics/bts199.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Jacoby GA
    . 2006. β-Lactamase nomenclature. Antimicrob Agents Chemother50:1123–1129. doi:10.1128/AAC.50.4.1123-1129.2006.
    OpenUrlFREE Full Text
  15. 15.↵
    1. Sigrist CJ,
    2. de Castro E,
    3. Cerutti L,
    4. Cuche BA,
    5. Hulo N,
    6. Bridge A,
    7. Bougueleret L,
    8. Xenarios I
    . 2013. New and continuing developments at PROSITE. Nucleic Acids Res41:D344–D347. doi:10.1093/nar/gks1067.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Dinakaran V,
    2. Shankar M,
    3. Jayashree S,
    4. Rathinavel A,
    5. Gunasekaran P,
    6. Rajendhran J
    . 2012. Genome sequence of Staphylococcus arlettae strain CVD059, isolated from the blood of a cardiovascular disease patient. J Bacteriol194:6615–6616. doi:10.1128/JB.01732-12.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Schwendener S,
    2. Perreten V
    . 2015. New shuttle vector-based expression system to generate polyhistidine-tagged fusion proteins in Staphylococcus aureus and Escherichia coli. Appl Environ Microbiol81:3243–3254. doi:10.1128/AEM.03803-14.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Schenk S,
    2. Laddaga RA
    . 1992. Improved method for electroporation of Staphylococcus aureus. FEMS Microbiol Lett73:133–138.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Zheng L,
    2. Baumann U,
    3. Reymond JL
    . 2004. An efficient one-step site-directed and site-saturation mutagenesis protocol. Nucleic Acids Res32:e115. doi:10.1093/nar/gnh110.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. CLSI
    . 2016. Performance standards for antimicrobial susceptibility testing; twenty-sixth informational supplement M100-S26. Clinical and Laboratory Standards Institute, Wayne, PA.
  21. 21.↵
    1. Bush K
    . 2013. The ABCD’s of β-lactamase nomenclature. J Infect Chemother19:549–559. doi:10.1007/s10156-013-0640-7.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Pires J,
    2. Novais A,
    3. Peixe L
    . 2013. Blue-carba, an easy biochemical test for detection of diverse carbapenemase producers directly from bacterial cultures. J Clin Microbiol51:4281–4283. doi:10.1128/JCM.01634-13.
    OpenUrlFREE Full Text
  23. 23.↵
    1. Fitzgerald JR,
    2. Monday SR,
    3. Foster TJ,
    4. Bohach GA,
    5. Hartigan PJ,
    6. Meaney WJ,
    7. Smyth CJ
    . 2001. Characterization of a putative pathogenicity island from bovine Staphylococcus aureus encoding multiple superantigens. J Bacteriol183:63–70. doi:10.1128/JB.183.1.63-70.2001.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Chen HJ,
    2. Tsai JC,
    3. Hung WC,
    4. Tseng SP,
    5. Hsueh PR,
    6. Teng LJ
    . 2011. Identification of fusB-mediated fusidic acid resistance islands in Staphylococcus epidermidis isolates. Antimicrob Agents Chemother55:5842–5849. doi:10.1128/AAC.00592-11.
    OpenUrlAbstract/FREE Full Text
  25. 25.
    1. Kreiswirth BN,
    2. Löfdahl S,
    3. Betley MJ,
    4. O’Reilly M,
    5. Schlievert PM,
    6. Bergdoll MS,
    7. Novick RP
    . 1983. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature305:709–712. doi:10.1038/305709a0.
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Download PDF
Citation Tools
Novel β-Lactamase blaARL in Staphylococcus arlettae
Sabrina N. Andreis, Vincent Perreten, Sybille Schwendener
mSphere May 2017, 2 (3) e00117-17; DOI: 10.1128/mSphere.00117-17

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print
Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this mSphere article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Novel β-Lactamase blaARL in Staphylococcus arlettae
(Your Name) has forwarded a page to you from mSphere
(Your Name) thought you would be interested in this article in mSphere.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Novel β-Lactamase blaARL in Staphylococcus arlettae
Sabrina N. Andreis, Vincent Perreten, Sybille Schwendener
mSphere May 2017, 2 (3) e00117-17; DOI: 10.1128/mSphere.00117-17
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • OBSERVATION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

antibiotic resistance
beta-lactamases
coagulase-negative staphylococci
penicillinase

Related Articles

Cited By...

About

  • About mSphere
  • Board of Editors
  • Policies
  • For Reviewers
  • For the Media
  • Embargo Policy
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Author Warranty
  • Types of Articles
  • Getting Started
  • Ethics
  • Contact Us

Follow #mSphereJ

@ASMicrobiology

       

 

Website feedback

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Online ISSN: 2379-5042